SENATE-BILL 2693: S.2693 - Biobased Market Expansion Act of 2025
AI-Powered Summary
SENATE-BILL 2693 aims to enhance the procurement of biobased products, primarily impacting consumers, businesses, and workers in the agricultural and manufacturing sectors by emphasizing domestic production. This legislation addresses key themes such as economic opportunity, sustainability, and compliance with constitutional provisions, particularly the Commerce Clause and the Buy American Act. Major provisions include requirements for federal agencies to prioritize biobased products, which may lead to increased availability and potentially lower prices for consumers. Additionally, training requirements for procurement officers are introduced to improve the efficiency of government purchasing processes. The bill mandates compliance and reporting measures to ensure transparency and accountability in government spending. Implementation will require federal agencies to adapt their procurement practices, with a focus on promoting domestic production and job creation. Potential implications include the risk of violating the Equal Protection Clause if the legislation disproportionately favors certain industries, while also aligning with national interests in sustainability and domestic economic growth.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill's focus on promoting biobased products through federal procurement processes has significant implications for individual rights, particularly concerning equal access and economic opportunities. While it aims to support job creation and environmental health, it may inadvertently create disparities that violate constitutional protections.
Key Individual Rights
Positive
- Economic rights through job creation in the biobased sector
- Potential health benefits from increased availability of environmentally friendly products
Negative
- Equal protection concerns if certain demographic groups are favored in procurement processes
- Due process issues related to regulatory burdens on small businesses and individuals
Constitutional Provisions
- Equal Protection Clause (14th Amendment)
- Due Process Clause (14th Amendment)
- Commerce Clause (Article I, Section 8)
Potential Constitutional Challenges
- Challenges may arise if the bill's implementation leads to unequal access to biobased products, particularly affecting marginalized communities.
- Small businesses may contest the regulatory burdens imposed by the bill, arguing that it infringes upon their rights to engage in commerce.
Summary
The Biobased Market Expansion Act of 2025 has the potential to create economic opportunities and promote environmental health, but it also raises significant constitutional concerns regarding equal protection and due process. The impact on various demographic groups will depend on how the bill is implemented, particularly in terms of access to biobased products and the regulatory environment for small businesses.
Constitutional Analysis
This bill has been analyzed for constitutional compliance using AI-powered analysis of constitutional principles and precedents.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention S. 2693 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
September 3, 2025
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat